The Indian pharmaceutical sector would soon be showcasing new drugs for malaria, oste porosis and diabetes, Union Minister for Science and Technology Harsh Vardhan said. The candidate drugs are currently undergoing clinical trials, he said.
Biocon’s chairman and managing director Kiran Mazumdar-Shaw, got 2nd rank in ‘The Medicine Maker Power List' 2015, an index of the 100 most influential people across the globe in the field of medicine. The top 5 in ‘The Medicine Maker Power List’ are: Anthony Fauci, director, National Institute of Allergy and Infectious Diseases, USA, Kiran Mazumdar-Shaw, chairman & managing director, Biocon, Sir Andrew Witty, chief executive officer, GlaxoSmithKline, Arthur D. Levinson, chief executive officer, Calico and Heather Bresch, chief executive officer of Mylan.
The US Food and Drug Administration (FDA) has approved Roche's cobas KRAS mutation test for diagnostic use. The real-time PCR test is designed to identify KRAS mutations in tumour samples from metastatic colorectal cancer (mCRC) patients and aid clinicians in determining a therapeutic path for them.
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
Also Join: 
.png)
